Home › Pagkabigo ng Puso › Oklahoma
Pag-aaral pangklinika para sa Pagkabigo ng Puso sa Oklahoma
16 pag-aaral para sa Pagkabigo ng Puso ang naghahanap ng mga kalahok sa mga site sa Oklahoma.
Mga Lungsod sa Oklahoma
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Oklahoma City
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Oklahoma State University Center for Health Sciences, Tulsa
Nagre-recruitPhase 3
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06736574Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- South Oklahoma Heart Research, Oklahoma City
Nagre-recruitPhase 3
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Oklahoma City
- Research Site, Oklahoma City
Nagre-recruitPhase 3
Edad 40 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Bartlesville, OK Investigative Site 10095, Bartlesville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06008197Pedal Pump Clinical Trial on Edema V2
- Hillcrest Medical Center, Tulsa
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07809516Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- Oklahoma Cardiovascular Research Group, Oklahoma City
Nagre-recruit
Edad 21 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05677100NORM-HF Pivotal Study
- Saint Francis Health System, Tulsa
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07574593Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Oklahoma City
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT00271180A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Oklahoma Heart Institute, Tulsa
Nagre-recruit
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07214376Alleviant ALLAY-HF Study
- South Oklahoma Heart Research, LLC., Oklahoma City
Nagre-recruit
Edad 40 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT05685303Pedal Pump Clinical Trial on Edema V1
- Hillcrest Medical Center, Tulsa
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT07760363Assessment of CCM in HF With Higher Ejection Fraction
- Oklahoma Heart Institute, Tulsa
- St. Francis Hospital - Tulsa, Tulsa
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT05064709Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
- Saint Francis Hospital, Tulsa
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT06552637Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Integris Baptist Medical Center, Oklahoma City
- Oklahoma Heart Institute at Utica, Tulsa
- Saint Francis Hospital, Tulsa
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT06526195The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Oklahoma Heart Institute Hospital, Tulsa
- Saint Francis Hospital,, Tulsa
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT03142152Mula sa ClinicalTrials.gov, na-kuha noong Set 29, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.